Trials / Conditions / Malignant Ovarian Clear Cell Tumor

Malignant Ovarian Clear Cell Tumor

4 registered clinical trials studyying Malignant Ovarian Clear Cell Tumor.

Status	Trial	Sponsor	Phase
Completed	Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell NCT03602586	National Cancer Institute (NCI)	Phase 2
Withdrawn	Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian NCT02470559	Barbara Ann Karmanos Cancer Institute	Phase 1
Completed	Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cance NCT02020707	Mayo Clinic	Phase 1
Terminated	YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal NCT00899093	Gynecologic Oncology Group	—